A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Completed · Phase 2

Conditions studied: Carcinoma, Renal Cell

In brief

To assess the safety and efficacy of SU011248 in patients with metastatic, refractory renal cell carcinoma

Key facts

Study ID
NCT00077974
Run by
Pfizer
People needed
106
Starts
2004-02-01
Expected to finish
2008-09-01
Last updated by the study team
2010-10-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.